TGFB1 and prostate carcinoma: Expression analysis of the TGF-β and BMP pathways (that both converge on SMAD4) revealed significantly reduced expression of TGF-β and BMP ligands in both untreated and castration resistant prostate cancer (Figure 6, Supplementary Figure 3).